Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Sickle Cell Disease Treatment With Arginine Therapy (STArT) Trial

ClinicalTrials.gov ID: NCT04839354

Public ClinicalTrials.gov record NCT04839354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The trial is designed to test intravenous (IV) arginine therapy in children with sickle cell disease (SCD) and vaso-occlusive painful episodes (VOE) to further knowledge on efficacy and safety of this orphan drug.

Study identification

NCT ID
NCT04839354
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Claudia R. Morris
Other
Enrollment
271 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
3 Years to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2021 (Actual)
Primary completion
Jul 11, 2024 (Actual)
Completion
Jul 11, 2024 (Actual)
Last update posted
Jun 23, 2026

2021 – 2024

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027 —
UCSF Benioff Children's Hospital San Francisco California 94158 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Children's Healthcare of Atlanta at Hughes Spalding Atlanta Georgia 03322 —
Children's Healthcare of Atlanta at Egleston Atlanta Georgia 30322 —
Washington University/St. Louis Children's Hospital St Louis Missouri 63110 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Texas Children's Hospital/Baylor College of Medicine Houston Texas 77030 —
Medical College of Wisconsin/Wisconsin Children's Hospital Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04839354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04839354 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →